Lv11
30 积分 2023-06-20 加入
The Drug-Dosing Conundrum in Oncology — When Less Is More
2小时前
待确认
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
21天前
已完结
Global epidemiology of epithelial ovarian cancer
28天前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
28天前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
1个月前
已完结
[Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China（2024 edition）]
1个月前
已完结
Evolution of the Ovarian Cancer Treatment Paradigm, Including Maintenance Treatment, in the US and Europe: A Real-World Chart Review Analysis (2017-2020) (028)
1个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
2个月前
已完结
Targeting KRAS in cancer
5个月前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
6个月前
已完结
皖公网安备34019202002308
